Studies on fibrin network structure in human plasma. Part One: Methods for clinical application

Area of Science:

• Biochemistry
• Hematology
• Medical Technology

Background:

• Fibrin fiber mass-length ratio is a key parameter in hemostasis and thrombosis research.
• Existing methods for measuring fibrin fiber characteristics were developed using pure fibrinogen solutions.
• The applicability of these methods to complex biological samples like human plasma requires validation.

Purpose of the Study:

• To evaluate the applicability of turbidity and permeability methods for measuring fibrin fiber mass-length ratio in human plasma.
• To critically examine the theoretical assumptions underlying these measurements in plasma.
• To investigate factors influencing the reproducibility and reliability of these methods in a clinical context.

Main Methods:

• Evaluation of turbidity and permeability-based methods for fibrin fiber mass-length ratio determination.
• Critical examination of theoretical assumptions for plasma measurements.
• Investigation of plasma handling techniques, reproducibility, anticoagulant effects, and influence of biological factors (age, sex, time, venepuncture, calcium, fibrinolytic inhibitors).

Main Results:

• Methods based on turbidity and permeability can be adapted for human plasma analysis.
• Theoretical assumptions require careful consideration when applied to plasma.
• Reproducibility is achievable with suitable standardization, accounting for various influencing factors.

Conclusions:

• Turbidity and permeability methods, when appropriately standardized, are acceptable for clinical studies assessing fibrin fiber characteristics in human plasma.
• These methods demonstrate reproducibility and can provide valuable data for understanding hemostasis and thrombosis.
• Further research should focus on refining standardization protocols for diverse clinical applications.